|
1
|
Lei SF, Wu S, Li LM, Deng FY, Xiao SM,
Jiang C, Chen Y, Jiang H, Yang F, Tan LJ, et al: An in vivo genome
wide gene expression study of circulating monocytes suggested GBP1,
STAT1 and CXCL10 as novel risk genes for the differentiation of
peak bone mass. Bone. 44:1010–1014. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cooper C, Westlake S, Harvey N, Javaid K,
Dennison E and Hanson M: Developmental origins of osteoporotic
fracture (Review). Osteoporos Int. 17:337–347. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu J, Shin Y, Yen MS and Sun SS: Peak bone
mass and patterns of change in total bone mineral density and bone
mineral contents from childhood into young adulthood. J Clin
Densitom. 19:180–191. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heaney RP, Abrams S, Dawson-Hughes B,
Looker A, Marcus R, Matkovic V and Weaver C: Peak bone mass.
Osteoporos Int. 11:985–1009. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou Y, Deng HW and Shen H: Circulating
monocytes: An appropriate model for bone-related study. Osteoporos
Int. 26:2561–2572. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiménez-Ortega RF, Ramírez-Salazar EG,
Parra-Torres AY, Muñoz-Montero SA, Rangel-Escareňo C,
Salido-Guadarrama I, Rodriguez-Dorantes M, Quiterio M, Salmerón J
and Velázquez-Cruz R: Identification of microRNAs in human
circulating monocytes of postmenopausal osteoporotic Mexican
Mestizo women: A pilot study. Exp Ther Med. 14:5464–5472.
2017.PubMed/NCBI
|
|
7
|
Deng FY, Liu YZ, Li LM, Jiang C, Wu S,
Chen Y, Jiang H, Yang F, Xiong JX, Xiao P, et al: Proteomic
analysis of circulating monocytes in Chinese premenopausal females
with extremely discordant bone mineral density. Proteomics.
8:4259–4272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Walsh B: Markov Chain Monte Carlo and
Gibbs Sampling. http://staff.ustc.edu.cn/~jbs/mcmc-gibbs-intro.pdfMarch
5–2017
|
|
9
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Irizarry RA, Bolstad BM, Collin F, Cope
LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe
level data. Nucleic Acids Res. 31:e152003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopaedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen P, Guo LH, Guo YK, Qu ZJ, Gao Y and
Qiu H: Identification of disturbed pathways in heart failure based
on Gibbs sampling and pathway enrichment analysis. Genet Mol Res.
15:2016.https://doi.org/10.4238/gmr.15027956.
|
|
13
|
Chen J, Wang L, Shen Y, Yu J, Ye T, Zhuang
C and Zhang W: Key genes associated with osteoporosis revealed by
genome wide gene expression analysis. Mol Biol Rep. 41:5971–5977.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Carraway R and Leeman SE: The amino acid
sequence of a hypothalamic peptide, neurotensin. J Biol Chem.
250:1907–1911. 1975.PubMed/NCBI
|
|
15
|
Patel AB, Tsilioni I, Leeman SE and
Theoharides TC: Neurotensin stimulates sortilin and mTOR in human
microglia inhibitable by methoxyluteolin, a potential therapeutic
target for autism. Proc Natl Acad Sci USA. E7049–E7058. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Law IK, Bakirtzi K, Polytarchou C,
Oikonomopoulos A, Hommes D, Iliopoulos D and Pothoulakis C:
Neurotensin - regulated miR-133α is involved in proinflammatory
signalling in human colonic epithelial cells and in experimental
colitis. Gut. 64:1095–1104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mustain WC, Rychahou PG and Evers BM: The
role of neurotensin in physiologic and pathologic processes. Curr
Opin Endocrinol Diabetes Obes. 18:75–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boules MM, Fredrickson P, Muehlmann AM and
Richelson E: Elucidating the role of neurotensin in the
pathophysiology and management of major mental disorders. Behav Sci
(Basel). 4:125–153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Obata K, Shimo T, Okui T, Matsumoto K,
Takada H, Takabatake K, Kunisada Y, Ibaragi S, Nagatsuka H and
Sasaki A: Tachykinin receptor 3 distribution in human oral squamous
cell carcinoma. Anticancer Res. 36:6335–6341. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Karpouzis A, Avgeridis P, Tripsianis G,
Gatzidou E, Kourmouli N and Veletza S: Assessment of tachykinin
receptor 3′ gene polymorphism rs3733631 in Rosacea. Int Sch Res
Notices. 2015:4694022015.PubMed/NCBI
|
|
21
|
Allan CM, Kalak R, Dunstan CR, McTavish
KJ, Zhou H, Handelsman DJ and Seibel MJ: Follicle-stimulating
hormone increases bone mass in female mice. Proc Natl Acad Sci USA.
107:22629–22634. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Zhang W, Yu C, Zhang X, Zhang H,
Guan Q, Zhao J and Xu J: Follicle-stimulating hormone increases the
risk of postmenopausal osteoporosis by stimulating osteoclast
differentiation. PLoS One. 10:e01349862015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng Y, Zhu S, Antaris AL, Chen H, Xiao Y,
Lu X, Jiang L, Diao S, Yu K, Wang Y, et al: Live imaging of
follicle stimulating hormone receptors in gonads and bones using
near infrared II fluorophore. Chem Sci (Camb). 8:3703–3711. 2017.
View Article : Google Scholar
|
|
24
|
Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang
Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, et
al: FSH directly regulates bone mass. Cell. 125:247–260. 2006.
View Article : Google Scholar : PubMed/NCBI
|
